Search results - 48 results
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
Neoplasms Abstract: In this diagnostic test validation study, we assessed the clinical accuracy and HPV genotyping performance of the INNO-LiPA HPV Genotyping II (INNO-LiPA) within the VALGENT-3 framework. ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
causally linked with the development of cervical precancer and cancer. HPV types 16 and 18 cause approximately 70% of cervical cancers worldwide. OBJECTIVES: To evaluate the harms and protection of ...
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
specimens for the detection of cervical precancer. However, insufficient evidence is available for specific HPV assay/self-sample device combinations. OBJECTIVES The VALHUDES protocol is designed as ...
Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel.
Abstract: Human papillomavirus (HPV) testing is being increasingly incorporated into cervical cancer screening. VALGENT (VAL idation of HPV GEN otyping Tests) is a framework designed to evaluate the clinical ...
Defining optimal triage strategies for hrHPV screen positive women- an evaluation of HPV 16/18 genotyping, cytology and p16/Ki-67 cyto-immunochemistry.
Lynne; Govan, Lynn; Black, Janice; Palmer, Tim; M. Arbyn Source: Cancer Epidemiol Biomarkers Prev (2017) Abstract: BACKGROUND: Several options for the triage of high-risk HPV screen positive (hrHPV+) women ...
Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.
Paul; Sankaranarayanan, Rengaswamy; Pillai, Madhavan Radhakrishna; Gangane, Nitin; Tommasino, Massimo; HPV-AHEAD study group Source: Int J Cancer, Volume 141, Issue 1, p.143-151 (2017) Keywords: Adult ...
Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD study.
Lucas, Eric; Anantharaman, Devasena; Gheit, Tarik; Castellsagué, Xavier; Pawlita, Michael; de Sanjosé, Silvia; Alemany, Laia; Tommasino, Massimo; M. Arbyn; Cindy Simoens; HPV-AHEAD study group Source: PLoS ...
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.
Human papillomaviruses (HPV s) are the necessary cause of most cervical cancers, a large proportion of other anogenital cancers, and a subset of oropharyngeal cancers. The knowledge about HPV has led to ...
Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Intraepithelial Lesions of the Cervix Uterine Cervical Neoplasms Vaginal Smears Abstract: BACKGROUND: In 2014, liquid-based cytology with HPV triage replaced conventional cytology. The aim of our study was to ...
HPV-based cervical cancer screening- facts, fiction, and misperceptions.
HPV-based cervical cancer screening is more effective than cytology-based screening. A pooled analysis of long-term follow-up data from these trials has shown reduced cervical cancer mortality in women ...